Our mission is to ensure that therapies work predictably for people fighting cancer. Notable is breathing new life into existing, de-risked drugs by combining them with a proprietary predicted responder diagnostic to create novel Presponse™ therapeutics that predictably achieve clinical benefit for the patient treated. We are committed to delivering value to our shareholders by building a sustainable, high-performance business.
